Our client NRGene closed its Initial Public Offering on the Tel Aviv Stock Exchange
28 January 2021
Our client, the AI genomics company, NRGene, closed its Initial Public Offering on the Tel Aviv Stock Exchange this week and raised NIS 100 million. NRGene develops artificial intelligence solutions that analyze genomics big data to enhance plants’ and animals’ natural breeding processes without genetic engineering. NRGene has already partnered with several leading global companies from 30 countries.
We thank our devoted team supporting this start-up, our partners Eyal Bar-Zvi and Efrat Tzur and associates Elina Shechter, Eilon Morag and Ofek Galipoliti.
For the article in Globes >> click here